Phase I/II Trial of a Combination of Anti-CD3/CD7 Immunotoxins for Steroid-Refractory Acute Graft-versus-Host Disease-Reference-Cited by-同舟云学术

Phase I/II Trial of a Combination of Anti-CD3/CD7 Immunotoxins for Steroid-Refractory Acute Graft-versus-Host Disease

Published:2019-04 Issue:4 Volume:25 Page:712-719
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Groth Christoph,van Groningen Lenneke F.J.,Matos Tiago R.,Bremmers Manita E.,Preijers Frank W.M.B.,Dolstra Harry,Reicherts Christian,Schaap Nicolaas P.M.,van Hooren Eric H.G.,IntHout Joanna,Masereeuw Rosalinde^ORCID,Netea Mihai G.,Levine John E.,Morales George,Ferrara James L.,Blijlevens Nicole M.A.,van Oosterhout Ypke V.J.M.,Stelljes Matthias,van der Velden Walter J.F.M.^ORCID

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference53 articles.

1. Secondary treatment of acute graft-versus-host disease: a critical review;Martin;Biol Blood Marrow Transplant,2012

2. Risk factors for steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation from matched related or unrelated donors;Calmettes;Biol Blood Marrow Transplant,2015

3. First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation;Martin;Biol Blood Marrow Transplant,2012

4. How I treat refractory acute GVHD;Deeg;Blood,2007

5. Acute graft-versus-host disease: from the bench to the bedside;Socié;Blood,2009

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in immunotoxin engineering: precision therapeutic strategies in modern oncology;Medical Oncology;2024-09-04

2. New investigational drugs for steroid-refractory acute graft-versus-host disease: a review of the literature;Expert Opinion on Investigational Drugs;2024-07-09

3. CD7 activation regulates cytotoxicity-driven pathology in systemic sclerosis, yielding a target for selective cell depletion;Annals of the Rheumatic Diseases;2023-12-18

4. Novel Pharmacological Treatment Options of Steroid-Refractory Graft-versus-Host Disease;Advances in Hematology;2023-12-06

5. Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002;Bone Marrow Transplantation;2023-09-25